ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

ACR Convergence 2025

October 24-29, 2025. Chicago, Illinois.

View by Number View by Title View Sessions

Monday, October 27, 2025

10:30AM-12:30PM
Abstract Number: 1252
Can LLMs Categorize Patient Priorities Like Humans? Comparing AI and Human Coders in Arthritis Nominal Group Discussions
(1248–1271) Patient Outcomes, Preferences, & Attitudes Poster II
10:30AM-12:30PM
Abstract Number: 1569
Can We Use Patient Reported Outcomes For Home-monitoring in SSc?
(1553–1591) Systemic Sclerosis & Related Disorders – Clinical Poster II
10:30AM-12:30PM
Abstract Number: 1392
Cancer Mortality in Sjogren’s Disease: Disproportionate Increase in Mortality from Cancers in Sjogren’s Disease Relative to All-Cancers
(1376–1404) Sjögren’s Disease – Basic & Clinical Science Poster II: Clinical Manifestations and Health Outcomes
10:30AM-12:30PM
Abstract Number: 1046
Cannabis Knowledge, Attitudes, and Practices Among Rheumatology Providers: Implications for Clinical Care and Education
(1038–1054) Health Services Research Poster II
10:30AM-12:30PM
Abstract Number: 1039
CAR-T Therapy in Rheumatoid Arthritis: A Health Systems Analysis of Cost and Global Equity
(1038–1054) Health Services Research Poster II
10:30AM-12:30PM
Abstract Number: 1334
Cardiac Biomarkers and Prediction of Major Cardiovascular Events in Rheumatoid Arthritis: Results from the ESPOIR Cohort
(1306–1346) Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II
10:30AM-12:30PM
Abstract Number: 1182
Cardiac Sarcoidosis in Black Patients: A Biopsy-Confirmed Cohort Study
(1147–1190) Miscellaneous Rheumatic & Inflammatory Diseases Poster II
10:30AM-12:30PM
Abstract Number: 1397
Cardiovascular And Cerebrovascular Risk In Sjögren’s Disease: Results From A Prospective Multicenter Cohort.
(1376–1404) Sjögren’s Disease – Basic & Clinical Science Poster II: Clinical Manifestations and Health Outcomes
10:30AM-12:30PM
Abstract Number: 0912
CD11c⁺CD21⁻ Autoimmune-Associated B Cells Derived from Double-Negative IgD⁻CD27⁻ Subsets Exhibit Enhanced IFNLR1 Expression in Systemic Lupus Erythematosus
(0897–0915) B Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster II
10:30AM-10:45AM
Abstract Number: 0857
CD14-dependent MAP kinase signaling is required for pathogenic neutrophil extracellular trap formation in APS
Abstracts: Antiphospholipid Syndrome (0855–0860)
10:30AM-12:30PM
Abstract Number: 1005
CD49a Contributes to Binding and Survival of Synovial Resident Memory T cells
(0978–1006) T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster
10:30AM-12:30PM
Abstract Number: 1070
Cervical Cancer and HPV Screening in Women with Lupus vs Healthy Control Group: A Retrospective Study at a Tertiary Referral Center
(1055–1087) Healthcare Disparities in Rheumatology Posters
10:30AM-12:30PM
Abstract Number: 1029
Cervical cancer screening rates in Korean women of childbearing age with systemic lupus erythematosus
(1007–1037) Epidemiology & Public Health Poster II
10:30AM-12:30PM
Abstract Number: 1094
Changes in NK cells and TH cell phenotype in Rheumatoid Arthritis patients treated with janus kinase inhibitors: implications for adverse effects
(1088–1122) Immunological Complications of Medical Therapy Poster
10:30AM-12:30PM
Abstract Number: 1472
Characteristics and Predictors of LLDAS in Survivors of Early Active Lupus: Insights from a Decade-Long Cohort
(1467–1516) Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster II
  • «Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 58
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology